Infection Control Market, By Type (Equipment, Services, Consumables and Accessories, Protective Barriers, Endoscope Reprocessing Products, Others), End User (Hospitals & Clinics, Pharmaceutical Companies, Medical Device Companies, Life Science Industry, Food Industry, Others), Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The global infection control market is anticipated to reach USD 26.4 billion by 2020 growing at a CAGR of 6.2% during the forecasting period, 2020-2028. Infection control helps in preventing and stopping the spread of infections in healthcare settings. It is grounded in infectious diseases, epidemiology, social science, and health system strengthening. Factors such as the rising number of surgical procedures and technological advancements in sterilization equipment are some of the major drivers for the infection control market
The global infection control market is segmented into type, end-user, and geography.
The type segment is segmented into Equipment, Services, Consumables and Accessories, Protective Barriers, Endoscope Reprocessing Products, and Others. The equipment segment is further segmented into Disinfectors segment, Washers, Flushers, Endoscope Reprocessor, and Sterilization Equipment. The sterilization equipment segment is further segmented into Heat Sterilization Equipment, Low-Temperature Equipment, Radiation Equipment, Filtration Equipment, Liquid Temperature Equipment, Others. The low-Temperature Equipment segment is further segmented into Hydrogen Peroxide Sterilization, Ethylene Oxide Sterilization (ETO), Formaldehyde Sterilization, and Others. The services segment is segmented into Contract Sterilization, Waste Disposal, and Other Hormonal Therapies. Contract Sterilization segment is further segmented into Ethylene Oxide Sterilization, E-Beam Sterilization, Gamma Sterilization, Steam Sterilization Services, and Others. Other Hormonal Therapies is further segmented into Zoladex (Goserelin Acetate), Faslodex (Fulvestrant), Halotestin (Fluoxymesterone). Consumables and Accessories segment is segmented into waste disposal, disinfectants and cleaning products, cleaning products, lubricants and cleaning solution, disinfection and cleaning accessories, sterilization indicators, personal protective equipment, packaging accessories, others. Protective Barriers segment is segmented into medical nonwovens, covers and closures, goggles. Endoscope Reprocessing Products is segmented into consumables and equipment.
The end-User segment is segmented into Hospitals & Clinics, Pharmaceutical Companies, Medical Device Companies, Life Science Industry, Food Industry, Others
Geographically, the global infection control market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions
North America region is the largest contributor to the infection control market in the forecast period 2020-2028 and the Asia-Pacific region is expected to grow with the highest CAGR during the forecast period 2020-2028.
Key players in the global infection control market are Novartis AG, Pfizer Inc., Merck & Co Inc., Janssen Global Services LLC, Celgene Corporation, Astellas Pharma Inc., Genzyme Corporation, F. Hoffman-LA Roche Pvt. Ltd, AstraZeneca, Abbvei Inc., Genentech, Inc., Celldex Therapeutics, Onyx Pharmaceuticals, Inc., Bionumerik Pharmaceuticals Inc, Eagle Pharma, Seattle Genetics, Smith & Nephew, Inc., Baxter, Bayer, Tesaro, Sanofi, Incyte Corporation, Immunomed among others
The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:
Hence, tremendous progress has been made over the last decade and yet a lot more to come in recent years.
Report Features |
Description |
---|---|
Market Revenue In 2020 |
USD 26.4 billion |
Growth Rate |
CAGR of 6.2% during the forecasting period, 2020-2028 |
Historical Data |
2017-2018 |
Forecast Years |
2020-2028 |
Base Year |
2019 |
Units Considered |
Revenue in USD billion and CAGR from 2020 to 2028 |
Report Segmentation |
Type, End-User, and Geography |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and the Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Novartis AG, Pfizer Inc., Merck & Co Inc., Janssen Global Services LLC, Celgene Corporation, Astellas Pharma Inc., Genzyme Corporation, F. Hoffman-LA Roche Pvt. Ltd, AstraZeneca, Abbvei Inc., Genentech, Inc., Celldex Therapeutics, Onyx Pharmaceuticals, Inc., Bionumerik Pharmaceuticals Inc, Eagle Pharma, Seattle Genetics, Smith & Nephew, Inc., Baxter, Bayer, Tesaro, Sanofi, Incyte Corporation, Immunomed |
Available Customization |
In addition to the market data for the infection control market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirements. |